A5061614290- Viral-associated cancers and disorders
- Lymphoma Diagnosis and Treatment
- Histiocytic Disorders and Treatments
- Chronic Lymphocytic Leukemia Research
- Esophageal Cancer Research and Treatment
- Venous Thromboembolism Diagnosis and Management
- Bacterial Infections and Vaccines
- Inflammatory Biomarkers in Disease Prognosis
- Mast cells and histamine
- Family and Disability Support Research
- Hemoglobinopathies and Related Disorders
- Renal Diseases and Glomerulopathies
- Gastric Cancer Management and Outcomes
- RNA regulation and disease
- Autoimmune and Inflammatory Disorders Research
- Eosinophilic Disorders and Syndromes
- Youth, Drugs, and Violence
- Neonatal Health and Biochemistry
- CNS Lymphoma Diagnosis and Treatment
- Pancreatic and Hepatic Oncology Research
- Long-Term Effects of COVID-19
- Heparin-Induced Thrombocytopenia and Thrombosis
- Methemoglobinemia and Tumor Lysis Syndrome
- Case Reports on Hematomas
- COVID-19 Clinical Research Studies
Beneficência Portuguesa de São Paulo
2020-2024
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2012-2021
Instituto do Câncer do Estado de São Paulo
2015-2021
Universidade de São Paulo
2019-2020
São Camilo Hospital
2020
Hospital São Paulo
2020
We report a second case of methemoglobinemia and non-autoimmune hemolytic anemia after contracting the SARS-CoV-2 infection in absence an identifiable eliciting drug. A 35-year old male without previous known comorbidities was admitted he diagnosed with COVID-19 had large pulmonary involvement. Seven days later, desaturated but any signs respiratory distress. check arterial blood gas revealed normal partial pressure oxygen follow-up tests confirmed diagnosis. Over next few days, hemolysis...
Abstract Background Inflammation status plays an important role in the natural history of malignancy. Consequently, hematological markers systemic inflammation may predict prognosis neoplasms. This study evaluated value cellular blood components changes during neoadjuvant chemoradiotherapy followed by esophagectomy for cancer predicting prognosis. Methods A cohort 149 patients was analyzed. Cellular were assessed before therapy (A); surgery (B); and 3 to 5 months after (C); following...
Biomarkers from routine complete blood count are known predictive factors of long-term outcomes in cancer patients. The value these biomarkers the setting trimodal therapy for esophageal predicting early postoperative is not studied.The present study evaluated cellular components changes during neoadjuvant chemoradiotherapy followed by curative intent esophagectomy mortality and morbidity.A cohort 149 consecutive patients that underwent using platinum- taxane-based regimens was analyzed....
To describe the incidence of thromboembolic events in adult patients with severe COVID-19 and identify clinical laboratory factors associated these events.Observational retrospective cohort study 243 admitted to an intensive care unit (ICU) at a Brazilian tertiary hospital.The all was 14.8%, which 3.8% developed deep vein thrombosis, 7.8% pulmonary embolism, 2.5% acute myocardial infarction, 1.2% stroke, peripheral artery occlusion. Risk identified were D-dimer admission >3000 ng/mL...
Chronic meningococcemia is a rare clinical presentation within the spectrum of infections due to Neisseria -en.jpg-en.jpgmeningitidis, which was first described in 1902. It defined as chronic and benign meningococcal bacteremia without meningeal signs or symptoms with at least one week's duration, characterized by intermittent continuous fever, polymorphic cutaneous rash, migratory arthropathy. The incidence believed be around 1:200,000 inhabitants. affects predominantly young people adults,...
Introduction: Diffuse Large B cell Lymphoma (DLBCL) is a heterogenous disease. Factors based on clinical and simple laboratory parameters are known widely used such as the Revised International Prognostic Index (R-IPI) National Comprehensive Cancer Network -IPI (NCCN-IPI). Thus, we aimed to report real world experience of outcomes DLBCL lymphoma patients treated in Brazilian public cancer institution evaluate prognostic role R-IPI NCCN-IPI. Methods: This an unicenter registry study including...